Answer Posted / ramireddy
THE DRUG SUBSTANCE HAS ACTIVE IN NATURE. IF WE ARE TAKING
IN SMALL AMOUNTS AT THE TIME OF DISEASE THAT SHOWS VERY
EFFECTIVE TO OUR BODY THE DRUG PRODUCT HAS HIGH PURITY
THAT IS ONLY USED FOR HUMAN BEINGS , AS PER ICH GUIDELINES
THE IMPURITY LEVEL IS SHOULD BE LESS THAN 0.1% ONLY THAT
DRUGS WE ARE USED FOR CURE OF ANY DISEASES BECASUSE THAT
HAS HIGH PURITY.
| Is This Answer Correct ? | 1 Yes | 4 No |
Post New Answer View All Answers
in which situation require to change rs specification?
What is mean by PDR?
how require to interprit the method precision data of hptlc?
What is similarity factor and its use in api strength?
How require to perform linearity as per ANVISA? What are the acceptance criteria?
A ha tc is actual defination of retention time?
what is difference in ods I ods II is this is realy from sorbent / packing characteristics or from other means
How to decide assay range for non pharmacopeial API analysis by HPLC? Could you give me any reference for same e.g Guidelines or Paper publications?
how to selecet an exact coloumn for an new molecule development by hplc how to select exact salt as buffer for new molecule development by hplc what is the the process to select the mode of saparation of compoundes by hplc what is the use of ph of buffer what is use of buffer,ph,organic phase,ans methods how the molecules get saparated in coloumn,
What is diffrence between extractable volume and deliverable volume? Answer pls
in stress study if your api not soluble in hcl naoh h2o2 then what require to do?
Please give idea about method development for cleaning method and how maco level establish
Colorimtry
which situation gc hs and gc als require to use?
What is rs test why we are performing rs test?